Although CP epithelium cell failure is described as an early sign in the etiology of AD (Giao et al., 2022), potential alteration of TTR levels in the CSF of AD patients is still controversial (Bergen et al., 2015; Riisoen, 1988; Serot et al., 1997; Tijms et al., 2024). This evidence concerns the gene TTR and Alzheimer disease.